Free Newsletter
Study: Lilly bone drug boosts fracture-healing
A new study could eventually boost Eli Lilly's osteoporosis drug Forteo. Researchers found that the bone med can jump-start healing of problematic fractures, making elderly patients' bones mend as if they were young again.
In a study of 145 patients with fractures that had gone unhealed for six months or more, 93 percent saw "significant healing" and pain control after eight to 12 weeks of Forteo therapy, according to a release. That study prompted an NIH-funded follow-up which is now underway--and researchers say their preliminary data appears to support Forteo's ablity to help stubborn fractures heal.
Some doctors are already using Forteo off-label to speed fracture-mending, researchers said. But if research proves that it's effective for hard-to-heal breaks such as pelvic fractures and spinal fractures, it could be adopted more broadly.
- check out the University of Rochester release
- see the HealthDay story in the Los Angeles Times
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: